← Back
$ARQT All transactions

Arcutis Biotherapeutics, Inc.

▼ SELL

$ Value

$105K

Shares

7,451

Price

$14

Filed

May 20

Insider

Name

Edwards Larry Todd

Title

See Remarks

CIK

0001994805

Roles

Officer

Transaction Details

Transaction Date

2025-05-19

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

183,104

Footnotes

The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of Restricted Stock Units ("RSUs") granted on February 22, 2024. | The price reported in Column 4 is a weighted average sale price. The shares were sold in multiple transactions at prices ranging from $13.6763 to $14.49, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.

Filing Info

Accession No.

0002065881-25-000009

Form Type

4

Issuer CIK

0001787306

Edwards Larry Todd's History

Date Ticker Type Value
2026-03-02 ARQT $90K
2026-03-02 ARQT $3K
2026-02-27 ARQT A $0
2026-02-27 ARQT A $0
2026-02-02 ARQT $52K
2025-11-06 ARQT $733K
2025-10-02 ARQT $84K
2025-10-02 ARQT $6K
2025-05-19 ARQT $105K

Other Insiders at ARQT (90d)

Insider Bought Sold Last
Leonard Keith R $997K 2026-03-02
Burnett Patrick
See Remarks
$505K 2026-03-02
Matsuda Masaru
See Remarks
$1.3M 2026-03-02
Welgus Howard G. $746K 2026-04-01
Watanabe Todd
See Remarks
$1.4M 2026-03-02
Edwards Larry Todd
See Remarks
$145K 2026-03-02
Vairavan Latha
SVP Chief Financial Officer
$106K 2026-03-02